Variant report
Variant | nsv517738 |
---|---|
Chromosome Location | chr2:34828378-34877933 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:34876891..34879240-chr2:34886043..34888561,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RASGRP3-3 | chr2:34860316-34860407 | ENSG00000226785 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113943141 | chr2:34829223-34829224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549289101 | chr2:34829241-34829242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568878617 | chr2:34829245-34829246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537813608 | chr2:34829251-34829252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563731682 | chr2:34829259-34829260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs557902329 | chr2:34829260-34829261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1819021 | chr2:34829291-34829292 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs533862150 | chr2:34829298-34829299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553336216 | chr2:34829327-34829328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138837813 | chr2:34829332-34829333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs542124807 | chr2:34829346-34829347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386644703 | chr2:34829417-34829418 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs142831421 | chr2:34829419-34829420 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575259975 | chr2:34829433-34829434 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544168459 | chr2:34829450-34829451 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147271481 | chr2:34829453-34829454 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377360522 | chr2:34829477-34829478 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138833109 | chr2:34829518-34829519 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs112116892 | chr2:34829535-34829536 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560130900 | chr2:34829561-34829562 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529044795 | chr2:34829574-34829575 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549301487 | chr2:34829581-34829582 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4362537 | chr2:34829588-34829589 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369961904 | chr2:34829590-34829591 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539530573 | chr2:34842227-34842228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139597932 | chr2:34842243-34842244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188893148 | chr2:34842251-34842252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs573648068 | chr2:34842252-34842253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541383207 | chr2:34842263-34842264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181990444 | chr2:34842270-34842271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs113212365 | chr2:34842322-34842323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189312181 | chr2:34842339-34842340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6717661 | chr2:34842351-34842352 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs563342068 | chr2:34842373-34842374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532513840 | chr2:34842374-34842375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs545854539 | chr2:34842406-34842407 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs559127889 | chr2:34842431-34842432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs528252808 | chr2:34842437-34842438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs76143965 | chr2:34842451-34842452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs568369694 | chr2:34842457-34842458 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs35961997 | chr2:34842463-34842464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs2030941 | chr2:34842489-34842490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs180882883 | chr2:34842517-34842518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530480114 | chr2:34842568-34842569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374877886 | chr2:34842646-34842647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539540530 | chr2:34842651-34842652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553075232 | chr2:34842673-34842674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79685243 | chr2:34842675-34842676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs535257190 | chr2:34842726-34842727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111439110 | chr2:34842739-34842740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:34829200-34829600 | Enhancers | Brain Germinal Matrix | brain |
2 | chr2:34829400-34829600 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr2:34842200-34842800 | Enhancers | Fetal Lung | lung |
4 | chr2:34860400-34861000 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr2:34875600-34875800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |